Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Gross Margin (2022 - 2025)

Cannabis Bioscience International Holdings' Gross Margin history spans 3 years, with the latest figure at 80.29% for Q4 2025.

  • For Q4 2025, Gross Margin fell 920.0% year-over-year to 80.29%; the TTM value through Nov 2025 reached 66.56%, down 2308.0%, while the annual FY2025 figure was 86.76%, 509.0% up from the prior year.
  • Gross Margin for Q4 2025 was 80.29% at Cannabis Bioscience International Holdings, up from 66.35% in the prior quarter.
  • Across five years, Gross Margin topped out at 95.33% in Q3 2024 and bottomed at 29.9% in Q1 2025.
  • The 3-year median for Gross Margin is 78.31% (2023), against an average of 68.81%.
  • The largest annual shift saw Gross Margin soared 2147bps in 2024 before it crashed -9747bps in 2025.
  • A 3-year view of Gross Margin shows it stood at 76.33% in 2023, then rose by 17bps to 89.49% in 2024, then decreased by -10bps to 80.29% in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Gross Margin are 80.29% (Q4 2025), 66.35% (Q3 2025), and 87.0% (Q2 2025).